ART-002(Ruizheng Gene)

N/A

Report date: 2025/07/30 13:53:49

Base Information

Drug NameART-002(Ruizheng Gene)
Drug Alias NameART002ART-002ART-002(Ruizheng Gene)
ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 modulators
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHeterozygous familial hypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesRuizheng Gene (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Bengbu Medical CollegeRuizheng Gene (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsHeterozygous familial hypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A